series-b
Stage
2
Investors
About
Mimetas develops advanced microfluidic tissue model platforms for drug discovery and biomedical research, enabling more predictive and ethical testing than traditional animal models.
Explore Mimetas's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.